Showing 191-200 of 325 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| S1P transport inhibitors for prevention of T1D | Rector & Visitors of the University of Virginia | Kevin Lynch | Cures | 01-October-2024 to 30-September-2026 | $520,627.00 |
| Anti-CD71 immunotherapy to restore T cell homeostasis in autoimmunity | Rector & Visitors of the University of Virginia | Kelsey Voss | Cures | 01-September-2025 to 31-August-2026 | $150,000.00 |
| The role of iron metabolism in T cell subsets in type 1 diabetes | Rector & Visitors of the University of Virginia | Kelsey Voss | Cures | 01-March-2025 to 28-February-2026 | $110,000.00 |
| Development of simulation tools to support adaptation of automated insulin delivery algorithms across pregnancies complicated by type 1 diabetes | Rector & Visitors of the University of Virginia | Jacopo Pavan | Improving Lives | 01-March-2025 to 28-February-2027 | $189,316.00 |
| Leveraging Real-Time Insulin Sensitivity Estimation for the Adaptation of a Fully-Closed Loop Automated Insulin Delivery System to Improve Glycemic Control in Adolescents with Type 1 Diabetes | Rector & Visitors of the University of Virginia | H. Marcela Moscoso Vasquez | Improving Lives | 01-April-2024 to 31-March-2026 | $189,709.00 |
| Dual Beta-cell Regenerative and Immunomodulatory Endogenous Agonist as a Replacement Therapy for Type 1 Diabetes | Rector & Visitors of the University of Virginia | Gordon Laurie | Cures | 01-October-2025 to 30-September-2027 | $300,000.00 |
| Clinical Validation of a Smart Bolus Calculator Informed by Insulin Sensitivity in Adults and Adolescents with Type 1 Diabetes | Rector & Visitors of the University of Virginia | Chiara Fabris | Improving Lives | 01-June-2020 to 31-December-2025 | $604,390.26 |
| Pancreatic Islet Transplantation for the Treatment of Type 1 Diabetes: In-Silico Developments to Support Clinical Advancements | Rector & Visitors of the University of Virginia | Chiara Fabris | Cures | 01-January-2025 to 31-December-2025 | $299,916.19 |
| Advancing Breakthroughs in Type 1 Diabetes Research with Safe and Immune Cloaked Stem Cells | Pluristyx | Benjamin Fryer | Cures | 15-November-2025 to 14-November-2027 | $704,860.20 |
| Inhibition of REDD1 Allostery as a Therapeutic for Type 1 Diabetes | Penn State College of Medicine | Michael Dennis | Improving Lives | 01-June-2024 to 31-May-2026 | $200,000.00 |